Clinical Evaluation of Two Daily Disposable Lenses in a Population of Daily Disposable (DD) Lens Wearers

Sponsor
CIBA VISION (Industry)
Overall Status
Completed
CT.gov ID
NCT00958828
Collaborator
(none)
178
2
2

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the performance of two daily disposable contact lenses in a population of daily disposable contact lens wearers.

Condition or Disease Intervention/Treatment Phase
  • Device: Nelfilcon A contact lens
  • Device: Narafilcon A contact lens
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
178 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of Two Daily Disposable Lenses in a Population of Daily Disposable (DD) Lens Wearers
Study Start Date :
Jul 1, 2009
Actual Primary Completion Date :
Sep 1, 2009
Actual Study Completion Date :
Sep 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Other: Nelfilcon A / Narafilcon A

Nelfilcon A contact lenses, then Narafilcon A contact lenses

Device: Nelfilcon A contact lens
Spherical, soft contact lens for daily disposable wear

Device: Narafilcon A contact lens
Spherical, soft contact lens for daily disposable wear

Other: Narafilcon A / Nelfilcon A

Narafilcon A contact lenses, then Nelfilcon A contact lenses

Device: Nelfilcon A contact lens
Spherical, soft contact lens for daily disposable wear

Device: Narafilcon A contact lens
Spherical, soft contact lens for daily disposable wear

Outcome Measures

Primary Outcome Measures

  1. Overall Lens Satisfaction [After 1 week of wear]

    Overall Lens Satisfaction, as interpreted by the subject and reported by the subject on a questionnaire as a single, retrospective evaluation of 1-week's wear time. Overall lens satisfaction was measured on a 10-point scale, with 1 being poor and 10 being excellent.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Currently wearing any spherical daily disposable contact lens except the two study products for at least 3 months prior to enrollment.

  • Currently wearing contact lenses at least 8 hours/day and 5 days/week.

  • Other protocol inclusion/exclusion criteria may apply.

Exclusion Criteria:
  • Eye injury or surgery within twelve weeks immediately prior to enrollment.

  • Currently enrolled in any clinical trial.

  • Prior history of corneal or refractive surgery.

  • Monovision correction.

  • Other protocol inclusion/exclusion criteria may apply.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • CIBA VISION

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
CIBA VISION
ClinicalTrials.gov Identifier:
NCT00958828
Other Study ID Numbers:
  • P-337-C-028
First Posted:
Aug 13, 2009
Last Update Posted:
Jul 10, 2012
Last Verified:
Jan 1, 2012
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Nelfilcon A / Narafilcon A Narafilcon A / Nelfilcon A
Arm/Group Description Nelfilcon A contact lenses, then Narafilcon A contact lenses Narafilcon A contact lenses, then Nelfilcon A contact lenses
Period Title: Period 1, 1 Week of Wear
STARTED 89 89
COMPLETED 89 88
NOT COMPLETED 0 1
Period Title: Period 1, 1 Week of Wear
STARTED 89 88
COMPLETED 89 87
NOT COMPLETED 0 1

Baseline Characteristics

Arm/Group Title Overall
Arm/Group Description This reporting group includes all enrolled and dispensed subjects.
Overall Participants 178
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
30.0
(12.1)
Sex: Female, Male (Count of Participants)
Female
111
62.4%
Male
67
37.6%

Outcome Measures

1. Primary Outcome
Title Overall Lens Satisfaction
Description Overall Lens Satisfaction, as interpreted by the subject and reported by the subject on a questionnaire as a single, retrospective evaluation of 1-week's wear time. Overall lens satisfaction was measured on a 10-point scale, with 1 being poor and 10 being excellent.
Time Frame After 1 week of wear

Outcome Measure Data

Analysis Population Description
Per protocol
Arm/Group Title Nelfilcon A Contact Lens Narafilcon A Contact Lens
Arm/Group Description Spherical, soft contact lens for daily disposable wear Spherical, soft contact lens for daily disposable wear
Measure Participants 174 175
Mean (Standard Deviation) [Units on a scale]
7.5
(2.2)
7.5
(2.3)

Adverse Events

Time Frame 39 days, duration of the trial
Adverse Event Reporting Description
Arm/Group Title Nelfilcon A Contact Lens Narafilcon A Contact Lens
Arm/Group Description Spherical, soft contact lens for daily disposable wear Spherical, soft contact lens for daily disposable wear
All Cause Mortality
Nelfilcon A Contact Lens Narafilcon A Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Nelfilcon A Contact Lens Narafilcon A Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/177 (0%) 0/178 (0%)
Other (Not Including Serious) Adverse Events
Nelfilcon A Contact Lens Narafilcon A Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/177 (0%) 0/178 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.

Results Point of Contact

Name/Title Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs
Organization CIBA VISION
Phone 1-800-241-7629
Email priya.janakiraman@cibavision.com
Responsible Party:
CIBA VISION
ClinicalTrials.gov Identifier:
NCT00958828
Other Study ID Numbers:
  • P-337-C-028
First Posted:
Aug 13, 2009
Last Update Posted:
Jul 10, 2012
Last Verified:
Jan 1, 2012